FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083465287> ?p ?o ?g. }

• W2083465287 endingPage "R458" @default.
• W2083465287 startingPage "R452" @default.
• W2083465287 abstract "Platelet P 2 Y 12 -ADP and COX-1 receptor inhibition with oral clopidogrel (CLO) and low-dose aspirin (ASA), respectively, attenuates reflex-mediated cutaneous vasodilation, but little is known about how these medications affect local vasodilatory signaling. Reactive hyperemia (RH) results in vasodilation that is mediated by sensory nerves and endothelium-derived hyperpolarization factors (EDHF) through large-conductance calcium-activated potassium channels, whereas slow local heating (LH) elicits vasodilation largely through the production of nitric oxide (NO). We hypothesized that CLO and ASA would attenuate locally mediated cutaneous vasodilation assessed by RH and LH (0.5°C/min). In a randomized, cross-over, double-blind placebo-controlled study, nine healthy men and women (56 ± 1 yr) took CLO (75 mg), ASA (81 mg), and placebo for 7 days. Skin blood flow was measured (laser-Doppler flowmetry, LDF) and cutaneous vascular conductance (CVC) was calculated (LDF/mean arterial pressure) and normalized to maximal CVC (%CVC max : 43°C and 28 mM sodium nitroprusside). RH response parameters, including area under the curve (AUC), total hyperemic response (THR), and the decay constant tau (λ) were calculated. NO-dependent vasodilation during LH was assessed by calculating the difference in %CVC max between a control site and an NO synthase-inhibited site (10 mM l-NAME: intradermal microdialysis). CLO augmented the AUC and THR (AUC clo = 3,783 ± 342; THR clo = 2,306 ± 266% CVC max /s) of the RH response compared with ASA (AUC ASA = 3,101 ± 325; THR ASA = 1,695 ± 197% CVC max /s) and placebo (AUC Placebo = 3,000 ± 283; THR Placebo = 1,675 ± 170% CVC max /s; all P < 0.0001 vs. CLO). There was no difference in the LH response or calculated NO-dependent vasodilation among treatments (all P > 0.05). Oral CLO treatment augments vasodilation during RH but not LH, suggesting that CLO may improve cutaneous microvascular function." @default.
• W2083465287 created "2016-06-24" @default.
• W2083465287 creator A5020687550 @default.
• W2083465287 creator A5024732141 @default.
• W2083465287 creator A5049007023 @default.
• W2083465287 creator A5075981203 @default.
• W2083465287 date "2013-08-15" @default.
• W2083465287 modified "2023-09-26" @default.
• W2083465287 title "Oral clopidogrel improves cutaneous microvascular function through EDHF-dependent mechanisms in middle-aged humans" @default.
• W2083465287 cites W1546150314 @default.
• W2083465287 cites W1574209656 @default.
• W2083465287 cites W1579655458 @default.
• W2083465287 cites W1968425289 @default.
• W2083465287 cites W1995369734 @default.
• W2083465287 cites W1996612583 @default.
• W2083465287 cites W2012559226 @default.
• W2083465287 cites W2014525756 @default.
• W2083465287 cites W2056273145 @default.
• W2083465287 cites W2060425241 @default.
• W2083465287 cites W2063557465 @default.
• W2083465287 cites W2072536636 @default.
• W2083465287 cites W2078476933 @default.
• W2083465287 cites W2085754775 @default.
• W2083465287 cites W2086890457 @default.
• W2083465287 cites W2102459986 @default.
• W2083465287 cites W2106576308 @default.
• W2083465287 cites W2130336900 @default.
• W2083465287 cites W2132186056 @default.
• W2083465287 cites W2145511029 @default.
• W2083465287 cites W2152623360 @default.
• W2083465287 cites W2157223254 @default.
• W2083465287 cites W2168250026 @default.
• W2083465287 cites W2200127855 @default.
• W2083465287 cites W2404727847 @default.
• W2083465287 doi "https://doi.org/10.1152/ajpregu.00366.2012" @default.
• W2083465287 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3833399" @default.
• W2083465287 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23804278" @default.
• W2083465287 hasPublicationYear "2013" @default.
• W2083465287 type Work @default.
• W2083465287 sameAs 2083465287 @default.
• W2083465287 citedByCount "15" @default.
• W2083465287 countsByYear W20834652872014 @default.
• W2083465287 countsByYear W20834652872015 @default.
• W2083465287 countsByYear W20834652872016 @default.
• W2083465287 countsByYear W20834652872017 @default.
• W2083465287 countsByYear W20834652872018 @default.
• W2083465287 countsByYear W20834652872019 @default.
• W2083465287 countsByYear W20834652872020 @default.
• W2083465287 countsByYear W20834652872021 @default.
• W2083465287 countsByYear W20834652872022 @default.
• W2083465287 crossrefType "journal-article" @default.
• W2083465287 hasAuthorship W2083465287A5020687550 @default.
• W2083465287 hasAuthorship W2083465287A5024732141 @default.
• W2083465287 hasAuthorship W2083465287A5049007023 @default.
• W2083465287 hasAuthorship W2083465287A5075981203 @default.
• W2083465287 hasBestOaLocation W20834652872 @default.
• W2083465287 hasConcept C120770815 @default.
• W2083465287 hasConcept C126322002 @default.
• W2083465287 hasConcept C134018914 @default.
• W2083465287 hasConcept C142724271 @default.
• W2083465287 hasConcept C185592680 @default.
• W2083465287 hasConcept C204787440 @default.
• W2083465287 hasConcept C27081682 @default.
• W2083465287 hasConcept C2779610285 @default.
• W2083465287 hasConcept C3019128504 @default.
• W2083465287 hasConcept C42219234 @default.
• W2083465287 hasConcept C50156730 @default.
• W2083465287 hasConcept C519581460 @default.
• W2083465287 hasConcept C529278444 @default.
• W2083465287 hasConcept C71924100 @default.
• W2083465287 hasConcept C98274493 @default.
• W2083465287 hasConceptScore W2083465287C120770815 @default.
• W2083465287 hasConceptScore W2083465287C126322002 @default.
• W2083465287 hasConceptScore W2083465287C134018914 @default.
• W2083465287 hasConceptScore W2083465287C142724271 @default.
• W2083465287 hasConceptScore W2083465287C185592680 @default.
• W2083465287 hasConceptScore W2083465287C204787440 @default.
• W2083465287 hasConceptScore W2083465287C27081682 @default.
• W2083465287 hasConceptScore W2083465287C2779610285 @default.
• W2083465287 hasConceptScore W2083465287C3019128504 @default.
• W2083465287 hasConceptScore W2083465287C42219234 @default.
• W2083465287 hasConceptScore W2083465287C50156730 @default.
• W2083465287 hasConceptScore W2083465287C519581460 @default.
• W2083465287 hasConceptScore W2083465287C529278444 @default.
• W2083465287 hasConceptScore W2083465287C71924100 @default.
• W2083465287 hasConceptScore W2083465287C98274493 @default.
• W2083465287 hasIssue "4" @default.
• W2083465287 hasLocation W20834652871 @default.
• W2083465287 hasLocation W20834652872 @default.
• W2083465287 hasLocation W20834652873 @default.
• W2083465287 hasLocation W20834652874 @default.
• W2083465287 hasOpenAccess W2083465287 @default.
• W2083465287 hasPrimaryLocation W20834652871 @default.
• W2083465287 hasRelatedWork W1973957642 @default.
• W2083465287 hasRelatedWork W1991088738 @default.
• W2083465287 hasRelatedWork W2046087928 @default.
• W2083465287 hasRelatedWork W2067365661 @default.
• W2083465287 hasRelatedWork W2099366831 @default.

• next